Chlamydophila pneumoniae attachment and infection in low proteoglycan expressing human lymphoid Jurkat cells

Microbial Pathogenesis

Volumn 51, Issue 3, 2011, Pages 209-216

  Kobayashi, Miho ^a,e   Ishida, Kasumi ^a   Matsuo, Junji ^a   Nakamura, Shinji ^b   Nagasawa, Ayumi ^a   Motohashi, Kazuki ^a   Yao, Takashi ^c   Hirai, Itaru ^d   Yamamoto, Yoshimasa ^d   Suzuki, Haruki ^e   Shimizu, Chikara ^e   Matsuno, Kazuhiko ^a,e   Yamaguchi, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Chlamydophila pneumoniae; Glycosaminoglycans; Heparin; Jurkat cells; Lymphocytes; Proteoglycans

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD4 ANTIGEN; GAG PROTEIN; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; PROTEOGLYCAN;

ARTICLE; BACTERIAL GROWTH; BACTERIAL TRANSLOCATION; BACTERIUM ADHERENCE; CD4+ T LYMPHOCYTE; CELL INCLUSION; CELL TYPE; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SECONDARY INFECTION; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIAL ADHESION; CELL LINE; CHLAMYDOPHILA PNEUMONIAE; EPITHELIAL CELLS; HUMANS; INCLUSION BODIES; JURKAT CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; PROTEOGLYCANS;

BACTERIA (MICROORGANISMS); CHLAMYDOPHILA PNEUMONIAE;

EID: 79959340983     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.03.010     Document Type: Article

References (46)

1. Grayston J.T. Chlamydia pneumoniae, strain TWAR. Chest 1989, 95:664-669.
2. Grayston J.T., Wang S.P., Kuo C.C., Campbell L.A. Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 1989, 8:191-202.
3. Kauppinen M., Saikku P. Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment. Clin Infect Dis 1995, 3(21 Suppl):S244-S252.
4. Grayston J.T. Chlamydia pneumoniae and atherosclerosis. Rev Med Interne 1996, 1(17 Suppl):S45-S47.
5. Hahn D.L., Dodge R.W., Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991, 266:225-230.
6. Norton R., Schepetiuk S., Kok T.W. Chlamydia pneumoniae pneumonia with endocarditis. Lancet 1995, 345:1376-1377.
7. Saario R., Toivanen A. Chlamydia pneumoniae as a cause of reactive arthritis. Br J Rheumatol 1993, 32:1112.
8. Ieven M.M., Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 2005, 43:19-24.
9. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson G.K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986, 6:131-138.
10. Sullivan G.W., Sarembock I.J., Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 2000, 67:591-602.
11. Matsumoto A., Higashi N., Tamura A. Electron microscope observation on the effects of polymixin B sulfate on cell walls of Chlamydia psittaci. J Bacteriol 1973, 113:357-364.
12. Matsumoto A., Manire G.P. Electron microscopic observations on the fine structure of cell walls of Chlamydia psittaci. J Bacteriol 1970, 104:1332-1337.
13. Rockey D.D., Matsumoto A. The chlamydial developmental cycles. Prokaryotic development 2000, 403-425. ASM Press, Washington D.C. Y.V. Brun, L.L. Shimkets (Eds.).
14. Haranaga S., Yamaguchi H., Friedman H., Izumi S., Yamamoto Y. Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro. Infect Immun 2001, 69:7753-7759.
15. Yamaguchi H., Haranaga S., Friedman H., Moor J.A., Muffly K.E., Yamamoto Y. A Chlamydia pneumoniae infection model using established human lymphocyte cell lines. FEMS Microbiol Lett 2002, 216:229-234.
16. Kaul R., Uphoff J., Wiedeman J., Yadlapalli S., Wenman W.M. Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease. Circulation 2000, 102:2341-2346.
17. Zhang J.P., Stephens R.S. Mechanism of C. trachomatis attachment to eukaryotic host cells. Cell 1992, 69:861-869.
18. Gutiérrez-Martín C.B., Ojcius D.M., Hsia R., Hellio R., Bavoil P.M., Dautry-Varsat A. Heparin-mediated inhibition of Chlamydia psittaci adherence to HeLa cells. Microb Pathog 1997, 22:47-57.
19. Taraktchoglou M., Pacey A.A., Turnbull J.E., Eley A. Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect Immun 2001, 69:968-976.
20. Wuppermann F.N., Hegemann J.H., Jantos C.A. Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae. J Infect Dis 2001, 184:181-187.
21. Moelleken K., Hegemann J.H. The Chlamydia outer membrane protein OmcB is required for adhesion and exhibits biovar-specific differences in glycosaminoglycan binding. Mol Microbiol 2008, 67:403-419.
22. Wuppermann F.N., Mölleken K., Julien M., Jantos C.A., Hegemann J.H. Chlamydia pneumoniae GroEL1 p.otein is cell surface associated and required for infection of HEp-2 cells. J Bacteriol 2008, 190:3757-3767.
23. Kjellen L., Lindahl U. Proteoglycans: structures and interactions. Annu Rev Biochem 1991, 60:443-475.
24. Rostand K.S., Esko J.D. Microbial adherence to and invasion through proteoglycans. Infect Immun 1997, 65:1-8.
25. + T cells. J Virol 2005, 79:12692-12702.
26. Clasper S., Vekemans S., Fiore M., Plebanski M., Wordsworth P., David G., et al. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action. J Biol Chem 1999, 274:24113-24123.
27. Ibrahim J., Griffin P., Coombe D.R., Rider C.C., James W. Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes. Virus Res 1999, 60:159-169.
28. Saphire A.C., Bobardt M.D., Zhang Z., David G., Gallay P.A. Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 2001, 75:9187-9200.
29. Sutton R.E., Littman D.R. Broad host range of human T-cell leukemia virus type 1 demonstrated with an improved pseudotyping system. J Virol 1993, 70:7322-7326.
30. Yamaguchi H., Matsuo J., Sugimoto S., Utsumi M., Yamamoto Y. Inhibition of lymphocyte CD3 expression by Chlamydophila pneumoniae infection. Microb Pathog 2008, 45:290-296.
31. Hirai I., Utsumi M., Yamaguchi H., Yamamoto Y. Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes. Can J Microbiol 2010, 56:289-294.
32. Dosch H.M., White D., Grant C. Reconstitution of nude mouse T cell function in vivo: IL 2-independent effect of human T cells. J Immunol 1985, 134:336-342.
33. Scidmore M.A., Fischer E.R., Hackstadt T. Sphingolipids and glycoproteins are differentially trafficked to the Chlamydia trachomatis inclusion. J Cell Biol 1996, 134:363-374.
34. Robertson D.K., Gu L., Rowe R.K., Beatty W.L. Inclusion biogenesis and reactivation of persistent Chlamydia trachomatis requires host cell sphingolipid biosynthesis. PLoS Pathog 2009, 5:e1000664.
35. Menozzi F.D., Mutombo R., Renauld G., Gantiez C., Hannah J.H., Leininger E., et al. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect Immun 1994, 62:769-778.
36. Noel G.J., Love D.C., Mosser D.M. High-molecular-weight proteins of nontypeable Haemophilus influenzae mediate bacterial adhesion to cellular proteoglycans. Infect Immun 1994, 62:4028-4033.
37. Van Putten J.P., Paul S.M. Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J 1995, 14:2144-2154.
38. Wegrowski Y., Milard A.L., Kotlarz G., Toulmonde E., Maquart F.X., Bernard J. Cell surface proteoglycan expression during maturation of human monocytes-derived dendritic cells and macrophages. Clin Exp Immunol 2006, 144:485-493.
39. Schofield K.P., Gallagher J.T., David G. Expression of proteoglycan core proteins in human bone marrow stroma. Biochem J 1999, 343(Pt 3):663-668.
40. Mölleken K., Schmidt E., Hegemann J.H. Members of the Pmp protein family of Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs. Mol Microbiol 2010, 78:1004-1017.
41. Mårdh P.A. Tubal factor infertility, with special regard to chlamydial salpingitis. Curr Opin Infect Dis 2004, 17:49-52.
42. Roblin P.M., Dumornay W., Hammerschlag M.R. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992, 30:1968-1971.
43. Gnoatto N., Lotufo R.F., Matsuda M., Penna V., Marquezini M.V. Expression of cell-surface heparan sulfate proteoglycans in human cyclosporin-induced gingival overgrowth. J Periodontal Res 2007, 42:553-558.
44. Virok D., Loboda A., Kari L., Nebozhyn M., Chang C., Nichols C., et al. Infection of U937 monocytic cells with Chlamydia pneumoniae induces extensive changes in host cell gene expression. J Infect Dis 2003, 188:1310-1321.
45. Dobra K., Andäng M., Syrokou A., Karamanos N.K., Hjerpe A. Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. Exp Cell Res 2000, 258:12-22.
46. Madico G., Quinn T.C., Boman J., Gaydos C.A. Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol 2000, 38:1085-1093.